ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.

Source:http://linkedlifedata.com/resource/pubmed/id/18628469

Clin. Cancer Res. 2008 Jul 15 14 14 4543-9

Download in:

View as

General Info

PMID
18628469